Apellis Pharmaceuticals, Inc. — Director's Dealing 2017

Nov 8, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Apellis Pharmaceuticals, Inc. (APLS)
CIK: 0001492422
Period of Report: 2017-11-08

Reporting Person: Potentia Holdings, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3826601	Direct

Footnotes

F1: Potentia Holdings, LLC ("Potentia")'s board of directors has voting and dispositive control over the shares held by Potentia. The members of the Potentia's board of directors are Cedric Francois, Alec Machiels, David Darst Jr., Stephen Gilles, Marie-Claude Bernal, Doug Onsi and A. Sinclair Dunlop. Because the board of directors acts by majority approval, none of the members of Potentia's board of directors has individual voting or investment power with respect to such shares.